Effective treatment of NMDs requires a multidisciplinary team experienced in the specific clinical needs of the conditions. With this in mind the following ‘sub-groups’ have been formed: muscle, nerve, motor neuron, mitochondrial and neuromuscular junction diseases. The healthcare providers actively participating in EURO-NMD form a critical mass of expertise that will enable the network to bring knowledge, multidisciplinary expertise and resources together across the disease areas to optimise diagnosis, care and treatment.

The network will cover all rare neuromuscular diseases with the main specialist groups (subdomains) being:

  • Rare muscle diseases (genetic, inflammatory, and metabolic)
  • Mitochondrial neuromuscular diseases
  • Neuromuscular junction defects (congenital myasthenic syndromes, autoimmune myasthenia)
  • Peripheral neuropathies (genetic and inflammatory)